Nomura Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-230
Closed -$22.6K 1515
2025
Q2
$22.6K Hold
230
﹤0.01% 1381
2025
Q1
$21.3K Hold
230
﹤0.01% 1410
2024
Q4
$20.9K Hold
230
﹤0.01% 1373
2024
Q3
$22.2K Hold
230
﹤0.01% 1367
2024
Q2
$21.1K Hold
230
﹤0.01% 1344
2024
Q1
$21.2K Hold
230
﹤0.01% 1370
2023
Q4
$21.9K Hold
230
﹤0.01% 1322
2023
Q3
$21.5K Buy
230
+120
+109% +$11.1K ﹤0.01% 1292
2023
Q2
$10.1K Hold
110
﹤0.01% 1505
2023
Q1
$8.09K Hold
110
﹤0.01% 1519
2022
Q4
$9.19K Hold
110
﹤0.01% 1470
2022
Q3
$10.6K Hold
110
﹤0.01% 1468
2022
Q2
$11.6K Hold
110
﹤0.01% 1490
2022
Q1
$19K Buy
+110
New +$16.4K ﹤0.01% 1428

Other funds holding AMED

Nomura Asset Management's AMED Position: Q3 2025 in Review

Nomura Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 230 shares — an estimated $22.6K sold.

Nomura Asset Management first reported a position in AMED in Q1 2022 and held it in 14 quarters. The position peaked at $22.6K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Nomura Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Nomura Asset Management sold 230 Amedisys shares in Q3 2025, an estimated $22.6K.
  • Nomura Asset Management first reported a position in Amedisys in Q1 2022 and held it in 14 quarters.
  • Nomura Asset Management's Amedisys position peaked at $22.6K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Nomura Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.